-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $56

Benzinga·01/09/2026 10:30:42
Listen to the news
Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $48 to $56.